A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.

Study Identifier
11182X-001
CT.gov Identifier
NCT02553772
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dry Eye
    • Study Drug
  • Carboxymethylcellulose Based Eye Drop
  • Carboxymethylcellulose Sodium 0.5%
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Used artificial tears for dry eye * Visual acuity of at least 20/32 (while wearing glasses, if necessary).
    Exclusion Criteria:
    * Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study * Herpes keratitis in the last 6 months * Cataract surgery, laser-assisted in situ keratomileusis \[LASIK\], or photorefractive keratectomy, within the last 6 months

    Protocol Summary

    This study will evaluate the safety and efficacy of a new eye drop formulation in patients with dry eye disease.

    Study Locations

    Location
    Status
    Location
    The Private Practice of Milton Hom, OD
    Azusa, California, United States, 91702
    Status
    Not applicable
    Location
    Havana Research Institute LLC
    Burbank, California, United States, 91506
    Status
    Not applicable
    Location
    Lugene Eye Institute
    Glendale, California, United States, 91204
    Status
    Not applicable
    Location
    Eric M. White, OD, INC
    San Diego, California, United States, 92123
    Status
    Not applicable
    Location
    Moyes Eye Center, PC
    Kansas City, Missouri, United States, 64154
    Status
    Not applicable
    Location
    Ophthalmology Associates
    St Louis, Missouri, United States, 63131
    Status
    Not applicable
    Showing {first} - {last} of {total} Results